Menu Search
Equities

PuraPharm Corp Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1498:HKG.HS

PuraPharm Corp Ltd

Actions
  • Price (HKD)0.33
  • Today's Change-0.005 / -1.49%
  • Shares traded9.50k
  • 1 Year change-37.74%
  • Beta0.3399
Data delayed at least 15 minutes, as of Feb 13 2026 07:40 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.

  • Revenue in HKD (TTM)346.76m
  • Net income in HKD-38.56m
  • Incorporated2011
  • Employees469.00
  • Location
    PuraPharm Corp LtdUnit 201-207, 2/F, Wireless Centre,Phase One, Hong Kong Science Park, Tai P Hong KongHKG
  • Phone+852 28401840
  • Fax+852 28400778
  • Websitehttps://www.purapharm.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.